274 related articles for article (PubMed ID: 15111785)
1. Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.
Raj A; Bertolone S; Cheerva A
J Pediatr Hematol Oncol; 2004 May; 26(5):312-4. PubMed ID: 15111785
[TBL] [Abstract][Full Text] [Related]
2. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation.
Corti P; Bonanomi S; Vallinoto C; Balduzzi A; Uderzo C; Cazzaniga G; Gaipa G; Dassi M; Perseghin P; Rovelli A
Acta Haematol; 2003; 109(1):43-5. PubMed ID: 12486323
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
Hess J; Su L; Nizzi F; Beebe K; Magee K; Salzberg D; Stahlecker J; Miller HK; Adams RH; Ngwube A
Transfusion; 2018 Sep; 58(9):2122-2127. PubMed ID: 30179262
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation.
Ship A; May W; Lucas K
Bone Marrow Transplant; 2002 Feb; 29(4):365-6. PubMed ID: 11896436
[No Abstract] [Full Text] [Related]
8. Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation.
Schuetz C; Hoenig M; Moshous D; Weinstock C; Castelle M; Bendavid M; Shimano K; Tolbert V; Schulz AS; Dvorak CC
Blood Adv; 2018 Oct; 2(19):2550-2553. PubMed ID: 30291113
[TBL] [Abstract][Full Text] [Related]
9. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
Ahmed I; Teruya J; Murray-Krezan C; Krance R
Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
[TBL] [Abstract][Full Text] [Related]
10. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab.
Gottardo NG; Baker DL; Willis FR
Pediatr Hematol Oncol; 2003; 20(7):557-61. PubMed ID: 12959862
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
[TBL] [Abstract][Full Text] [Related]
12. [Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune hemolytic anemia].
Wang L; Xu W; Li JY; Xie XY; Sheng RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):425-8. PubMed ID: 17493362
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
Minakawa K; Ohto H; Yasuda H; Saito S; Kawabata K; Ogawa K; Nollet KE; Ikeda K
Transfusion; 2018 Jul; 58(7):1606-1610. PubMed ID: 29664112
[TBL] [Abstract][Full Text] [Related]
14. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
Ramanathan S; Koutts J; Hertzberg MS
Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
Endo T; Nakao S; Koizumi K; Nishio M; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
[TBL] [Abstract][Full Text] [Related]
17. Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab.
Ryeon Lee S; Lee SY; Nam MH; Park Y; Jong Park S; Jung Sung H; Won Choi C; Soo Kim B
Leuk Lymphoma; 2011 Mar; 52(3):528-30. PubMed ID: 21275632
[No Abstract] [Full Text] [Related]
18. Immune hemolytic anemia--selected topics.
Hoffman PC
Hematology Am Soc Hematol Educ Program; 2009; ():80-6. PubMed ID: 20008185
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.
Wang M; Wang W; Abeywardane A; Adikarama M; McLornan D; Raj K; de Lavallade H; Devereux S; Mufti GJ; Pagliuca A; Potter VT; Mijovic A
Biol Blood Marrow Transplant; 2015 Jan; 21(1):60-6. PubMed ID: 25262883
[TBL] [Abstract][Full Text] [Related]
20. Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT.
Simms-Waldrip T; Ikeda A; Goldfinger D; Moore T; Yuan S
Bone Marrow Transplant; 2010 Jan; 45(1):201-2. PubMed ID: 19448677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
